Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
India flag India · Delayed Price · Currency is INR
554.50
+3.70 (0.67%)
Last updated: Jul 15, 2025

NSE:AKUMS Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jul '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
85,25574,479----
Enterprise Value
80,53871,969----
Last Close Price
556.85473.20----
PE Ratio
24.6422.02----
Forward PE
24.9922.14----
PS Ratio
2.071.81----
PB Ratio
2.782.43----
P/TBV Ratio
2.812.45----
P/FCF Ratio
44.2038.61----
P/OCF Ratio
18.3316.01----
PEG Ratio
-0.69----
EV/Sales Ratio
1.951.75----
EV/EBITDA Ratio
17.1615.76----
EV/EBIT Ratio
25.2922.60----
EV/FCF Ratio
41.7537.31----
Debt / Equity Ratio
0.030.030.790.860.640.15
Debt / EBITDA Ratio
0.190.191.162.070.980.45
Debt / FCF Ratio
0.460.463.03--2.75
Asset Turnover
1.081.081.231.151.40-
Inventory Turnover
3.813.813.853.244.19-
Quick Ratio
1.511.510.920.800.781.07
Current Ratio
2.552.551.601.521.492.00
Return on Equity (ROE)
18.17%18.17%0.11%14.51%-33.18%-
Return on Assets (ROA)
5.22%5.22%6.72%3.74%7.54%-
Return on Capital (ROIC)
8.97%8.97%17.31%9.99%19.31%-
Return on Capital Employed (ROCE)
9.90%9.90%15.80%9.50%17.60%14.20%
Earnings Yield
3.97%4.54%----
FCF Yield
2.26%2.59%----
Buyback Yield / Dilution
-4.58%-4.58%----
Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.